[关键词]
[摘要]
激光光凝是视网膜疾病治疗的重要手段之一，时至今日，视网膜激光仍在不断发展。以往数十年，研究者试图发现一种既可以减少组织损伤，同时又能达到最佳治疗效果的激光治疗。577 nm阈下微脉冲激光(subthreshold micropulse laser， SML)因其光毒性低、散射小、穿透力较强，与传统激光相比损伤小、反应轻、无疼痛等特点，让这一目标不再是梦想，使激光治疗眼底疾病进入了一个新时代。本文就577 nm SML的概念、作用机制、相关参数及在多种视网膜疾病中的临床应用进展进行综述，希望予临床治疗以参考。
[Key word]
[Abstract]
Laser photocoagulation is one of the important methods for treating retinal diseases, and retinal laser technology continues to advance. For decades, researchers have been striving to find a laser treatment that can minimize tissue damage while achieving optimal results. With low toxicity, low scattering light, strong penetrating power, small compared with the traditional laser damage, light reaction and no pain, the 577 nm subthreshold micropulse laser(SML)turns this goal into reality and ushers in a new era of laser treatment for fundus diseases. This article reviews the concept, mechanism, related parameters and clinical application progress of 577 nm SML in a variety of retinal diseases, aiming to provide references for clinical treatments.
[中图分类号]
[基金项目]
爱尔眼科医院集团临床研究所科研基金项目(No.AR2110D17)
